| abstract |
Methods of inhibiting influenza virus replication in a biological sample or in a patient, reducing the amount of influenza virus in a biological sample or in a patient and treating influenza in a patient include administering to the specified biological sample or patient an effective amount of a compound corresponding to structural formula (I) or a pharmaceutically acceptable salt thereof where the variables of structural formula (I) are as described in the present description. The compound corresponds to the structural formula (I) or the structural formula of its pharmaceutically acceptable salt, where the variables of the structural formula (I) are as described in the present description. The pharmaceutical composition contains an effective amount of such a compound or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle. |